Down-regulation of the expression of angiotensin II type 1 receptor in neonatal rat cardiac fibroblast by activation of PPARγ signal pathway

Chinese Journal of Physiology

Volumn 51, Issue 6, 2008, Pages 357-362

  Zhao, Shu Mei ^a   Shen, Lu Hua ^a   Li, Hong Wei ^a   Wang, Lei ^a   Chen, Hui ^a   Wang, Yong Ling ^a   Guo, Chun Yan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Actinomycin D; Angiotensin II type 1 receptor; Cardiac fibrosis; PPAR agonist

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COLLAGEN TYPE 2; COLLAGEN TYPE 3; DACTINOMYCIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; COLLAGEN TYPE 1;

ANIMAL CELL; ARTICLE; CARDIAC FIBROBLAST; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE FIBROSIS; MOLECULAR MECHANICS; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL SURVIVAL; DOWN REGULATION; GENETICS; HEART MUSCLE; METABOLISM; RNA STABILITY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; DOWN-REGULATION; FIBROBLASTS; MYOCARDIUM; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA STABILITY; SIGNAL TRANSDUCTION;

EID: 66149091129     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Asakawa, M., Takano, H., Nagai, T., Uozumi, H., Hasegawa, H., Kubota, N., Saito, T., Masuda, Y., Kadowaki, T. and Komuro, I. Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 105: 1240-1246, 2002.
2. Burgess, H.A., Daugherty, L.E., Thatcher, T.H., Lakatos, H.F., Ray, D.M., Rednnet, M., Phipps, R.P. and Sime, P.J. PPARgamma agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am. J. Physiol. Lung. Cell. Mol. Physiol. 288: L1146-1153, 2005.
3. Calkin, A.C., Forbes, J.M., Smith, C.M., Lassila, M., Cooper, M.E., Jandeleit-Dahm, K.A. and Allen, T.J. Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arterioscler. Thromb. Vasc. Biol. 25: 1903-1909, 2005.
4. Chen, K., Chen, J., Li, D., Zhang, X. and Mehta, J.L. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: Modulation by PPAR-γ ligand pioglitazone. Hypertension 44: 655-661, 2004;
5. Diep, Q.N., Benkirane, K., Amiri, F., Cohn, J.S., Endemann, D. and Schiffrin, E.L. PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J. Mol. Cell. Cardiol. 36: 295-304, 2004.
6. Gralinski M.R., Rowse P.E. and Breider M.A. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro. J. Cardiovasc. Pharmacol. 31: 909-913, 1998.
7. Ichiki, T., Usui, M., Kato, M., Funakoshi, Y., Ito, K., Egashira, K. and Takeshita, A. Downregulation of Angiotensin II Type I receptor gene transcription by nitric oxide. Hypertension 31: 342-348, 1998.
8. Law, R.E., Goetze, S., Xi, X.P., Jacksom, S., Kawano, Y., Demeer, L., Fishbein, M.C., Meehan, W.P. and Hsueh, W.A. Expression and function of PPAR in rat and human vascular smooth muscle cells. Circulation 101: 1311-1318, 2000.
9. Li, B., Ma, Y.X., Xie, J.,Yang, B., Li, Z., Wang, H.Z., Zhang, D. and Niu, B. Rosiglitazone improves post-infarction left ventricular contractile function in rats. Chinese Med. J. 118: 1028-1031, 2005.
10. Liu, H.R., Tao, L., Gao, E., Lopez, B.L., Christopher, T.A., Willette, R.N., Ohlstein, E.H., Yue, T.L. and Ma, X.L. Antiapoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc. Res. 62: 135-144, 2004.
11. Makino N., Sugano M. and Masutomo K. Matrix degradation enzyme activities on cardiac remodeling in heart failure in cardiac remodeling and failure. Boston 2003; Kluwer. Academic. pp. 305-318.
12. Makino, N., Sugano, M., Satoh, S., Oyama, J. and Maeda, T. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. Cell Biochem. Biophys. 44: 65-71, 2006.
13. Panchapakesan, U., Sumual, S., Pollock, C.A. and Chen, X. PPARgamma agonists exert antifibrotic effects in renal tubularcells exposed to high glucose. Am. J. Physiol. Renal. Physiol. 289: F1153-1158, 2005.
14. Simpson, P., McGrath, A. and Savion, S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ. Res. 51: 787-801, 1982.
15. Takeda, K., Ichiki, T., Tokunou, T., Funakoshi, Y., Iino, N., Hirano, K., Kanaide, H. and Takshita, A. Peroxisome proliferator-activated receptor γ activators downregulate Angiotensin II Type I receptor in vascular smooth muscle cells. Circulation 102: 1834-1839, 2000.
16. Westrloo, D.J., Florquin, S., Boer A.M., Daalhuisen, J., Vos, A.F., Bruno, M.J. and Poll, T. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am. J. Pathol. 66: 721-728, 2005.